非外科的隆鼻術市場 - 世界の産業規模、シェア、動向、機会、予測、フィラータイプ別、用途別、最終用途別、地域別、競合別、2020年～2030年

世界の非外科的隆鼻術市場は、2024年に7億5,235万米ドルと評価され、予測期間中に8.06％の複合年間成長率（CAGR）で成長し、2030年までに11億9,956万米ドルに達すると予測されています。

この市場は近年、非侵襲的な美容強化に対する需要の高まりに後押しされ、大幅な成長と進化を遂げています。従来の外科的処置に代わるものとして、一般に「リキッドノーズジョブ」として知られる非外科的隆鼻術に注目する消費者が増えています。

この低侵襲技術では、注射可能な皮膚充填剤を使用することで、手術の必要なく鼻の輪郭を整え、強調することができます。施術は通常1時間以内で完了し、患者はほとんどすぐに日常生活を再開できるため、活動的なライフスタイルを送る人にとって魅力的なソリューションとなります。外科的な隆鼻術と比較して、回復時間が大幅に短縮され、リスクも最小限に抑えられ、即座に顕著な結果が得られることが、人気の高まりに寄与しています。

市場促進要因

低侵襲の美容処置に対する需要の高まり

市場の課題

安全性への懸念と規制のばらつき

市場動向

技術的進歩が市場の革新を促進

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の非外科的隆鼻術市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • フィラータイプ別（ヒアルロン酸フィラー、CaHaフィラー）
  • 用途別（凸鼻、鼻背の陥入、軽度の鼻非対称、その他）
  • 最終用途別（メッドスパ、病院/手術センター、医療従事者所有のクリニック）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米の非外科的隆鼻術市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の非外科的隆鼻術市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の非外科的隆鼻術市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の非外科的隆鼻術市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの非外科的隆鼻術市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific, Inc.
• SKINovative of Gilbert-Medical Spa
• The London Cosmetic Clinic
• Laser Clinic United Kingdom
• Therapie Clinic
• Toronto Cosmetic Clinic（TCC）
• Canada MedLaser, Inc.
• Skin Vitality Medical Clinic
• True MediSpa Skin & Laser Clinic
• Nova Aesthetic Clinic
• VIVA Skin Clinic
• Piedmont Plastic Surgery & Dermatology

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Non Surgical Rhinoplasty market was valued at USD 752.35 million in 2024 and is projected to reach USD 1,199.56 million by 2030, growing at a compound annual growth rate (CAGR) of 8.06% during the forecast period. This market has witnessed substantial growth and evolution in recent years, driven by the rising demand for non-invasive cosmetic enhancements. Increasingly, consumers are turning to non-surgical rhinoplasty-commonly known as the "liquid nose job"-as a preferred alternative to traditional surgical procedures.

This minimally invasive technique involves the use of injectable dermal fillers to reshape and enhance nasal contours without the need for surgery. The procedure is typically completed in under an hour and allows patients to resume daily activities almost immediately, offering an appealing solution for individuals with active lifestyles. Compared to surgical rhinoplasty, it offers significantly reduced recovery time, minimal risk, and instant, noticeable results-factors contributing to its growing popularity.

Market Drivers

Rising Demand for Minimally Invasive Aesthetic Procedures

The healthcare sector has been shifting toward less invasive treatment options, with consumers increasingly seeking alternatives to conventional surgery. This trend is supported by benefits such as shorter recovery periods, reduced procedural risks, and lower costs. According to the American Society of Plastic Surgeons (ASPS), minimally invasive cosmetic procedures in the U.S. increased by 7% in 2023, surpassing the growth rate of surgical treatments.

Non-surgical rhinoplasty has become a prominent trend within the broader aesthetic medicine space. Its appeal lies in the absence of incisions and sutures, resulting in lower levels of discomfort and downtime. The procedure offers a high degree of customization, allowing practitioners to tailor treatments to individual facial structures and patient preferences. As consumer interest grows, the market is expected to continue its upward trajectory, supported by ongoing advancements in technology and product development.

Market Challenges

Safety Concerns and Regulatory Variability

Despite its non-invasive nature, non-surgical rhinoplasty presents certain safety challenges that could hinder market expansion. The use of dermal fillers-primarily hyaluronic acid-carries risks such as vascular occlusion, which can lead to complications including tissue necrosis or vision impairment. The nasal area's complex vascular structure heightens the potential for adverse outcomes, especially when procedures are performed by inadequately trained or unlicensed individuals.

Additionally, inconsistent regulatory standards across regions contribute to variable treatment quality and outcomes. In some countries, oversight regarding qualified practitioners and approved materials is limited. The proliferation of counterfeit or substandard fillers further elevates the risk, leading to patient hesitation. Negative media coverage of botched procedures amplifies public concerns. Enhancing patient and provider education, standardizing training protocols, and implementing stricter regulations will be essential to build consumer confidence and ensure procedural safety.

Market Trends

Technological Advancements Driving Market Innovation

Technological innovation is playing a pivotal role in the evolution of the non-surgical rhinoplasty market. Recent developments in dermal filler formulations-particularly those using hyaluronic acid-have led to safer, more durable, and more effective products. These advancements have significantly improved patient satisfaction and procedural outcomes.

Cutting-edge tools such as 3D imaging and simulation software are transforming the consultation process, enabling both practitioners and patients to visualize expected results in advance. This not only enhances precision but also builds greater trust and transparency between provider and client.

Further, the emergence of needle-free injection systems is reducing discomfort and bruising, making the procedure even more accessible to needle-averse individuals. Long-lasting fillers that maintain their effects for up to two years are also gaining traction, offering a more cost-effective and convenient solution for patients.

As technology continues to advance, the non-surgical rhinoplasty market is expected to benefit from greater procedural efficiency, improved patient outcomes, and expanded treatment capabilities, positioning it for sustained growth.

Key Market Players

• Thermo Fisher Scientific, Inc.
• SKINovative of Gilbert - Medical Spa
• The London Cosmetic Clinic
• Laser Clinic United Kingdom
• Therapie Clinic
• Toronto Cosmetic Clinic (TCC)
• Canada MedLaser, Inc.
• Skin Vitality Medical Clinic
• True MediSpa Skin & Laser Clinic
• Nova Aesthetic Clinic
• VIVA Skin Clinic
• Piedmont Plastic Surgery & Dermatology

Report Scope:

In this report, the Global Non-surgical Rhinoplasty Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-surgical Rhinoplasty Supplements Market, By Filler Type:

• Hyaluronic Acid Filler
• CaHa Filler

Non-surgical Rhinoplasty Supplements Market, By Application:

• Convex Nose
• Indentations of dorsal hump
• Minor Nasal Asymmetry
• Others

Non-surgical Rhinoplasty Supplements Market, By End-use:

• MedSpa
• Hospital/Surgery Center
• HCP-owned Clinic

Non-surgical Rhinoplasty Supplements Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-surgical Rhinoplasty.

Available Customizations:

Global Non-surgical Rhinoplasty report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Non-surgical Rhinoplasty Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Filler Type (Hyaluronic Acid Filler, CaHa Filler)
  • 5.2.2. By Application (Convex Nose, Indentations of dorsal hump, Minor Nasal Asymmetry, Others)
  • 5.2.3. By End-use (MedSpa, Hospital/Surgery Center, HCP-owned Clinic)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Non-surgical Rhinoplasty Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Filler Type
  • 6.2.2. By Application
  • 6.2.3. By End-use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Non-surgical Rhinoplasty Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Filler Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-use
  • 6.3.2. Mexico Non-surgical Rhinoplasty Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Filler Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-use
  • 6.3.3. Canada Non-surgical Rhinoplasty Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Filler Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-use

7. Europe Non-surgical Rhinoplasty Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Filler Type
  • 7.2.2. By Application
  • 7.2.3. By End-use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Non-surgical Rhinoplasty Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Filler Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-use
  • 7.3.2. Germany Non-surgical Rhinoplasty Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Filler Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-use
  • 7.3.3. United Kingdom Non-surgical Rhinoplasty Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Filler Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-use
  • 7.3.4. Italy Non-surgical Rhinoplasty Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Filler Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-use
  • 7.3.5. Spain Non-surgical Rhinoplasty Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Filler Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-use

8. Asia-Pacific Non-surgical Rhinoplasty Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Filler Type
  • 8.2.2. By Application
  • 8.2.3. By End-use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Non-surgical Rhinoplasty Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Filler Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Non-surgical Rhinoplasty Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Filler Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-use
  • 8.3.3. South Korea Non-surgical Rhinoplasty Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Filler Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-use
  • 8.3.4. Japan Non-surgical Rhinoplasty Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Filler Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Non-surgical Rhinoplasty Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Filler Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-use

9. South America Non-surgical Rhinoplasty Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Filler Type
  • 9.2.2. By Application
  • 9.2.3. By End-use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Non-surgical Rhinoplasty Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Filler Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-use
  • 9.3.2. Argentina Non-surgical Rhinoplasty Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Filler Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-use
  • 9.3.3. Colombia Non-surgical Rhinoplasty Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Filler Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-use

10. Middle East and Africa Non-surgical Rhinoplasty Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Filler Type
  • 10.2.2. By Application
  • 10.2.3. By End-use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Non-surgical Rhinoplasty Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Filler Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-use
  • 10.3.2. Saudi Arabia Non-surgical Rhinoplasty Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Filler Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-use
  • 10.3.3. UAE Non-surgical Rhinoplasty Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Filler Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. SKINovative of Gilbert - Medical Spa
• 14.3. The London Cosmetic Clinic
• 14.4. Laser Clinic United Kingdom
• 14.5. Therapie Clinic
• 14.6. Toronto Cosmetic Clinic (TCC)
• 14.7. Canada MedLaser, Inc.
• 14.8. Skin Vitality Medical Clinic
• 14.9. True MediSpa Skin & Laser Clinic
• 14.10. Nova Aesthetic Clinic
• 14.11. VIVA Skin Clinic
• 14.12. Piedmont Plastic Surgery & Dermatology

15. Strategic Recommendations

16. About Us & Disclaimer